Search:

Search for text in:

separate each search
term with a space

Multiple terms:

Additional Search Filters:

clear all | select all

Conferences:

clear all | select all

Conference Years:

clear all | select all

Days Within Meeting:

Has CME:

Do I Have Access?

Access:

Availability:

clear all | select all

Participation Type:

clear all | select all

Categories:

What's New in 131-I Refractory Thyroid Cancer?

Browse by: Sort by:
<< first | < prev page: of 1 records per page: next > | last >>
pages: 1 presentations: 1 to 4 of 4
What's New in 131-I Refractory Thyroid Cancer?
Targeting the Sodium Iodide Symporter to Increase RAI Uptake
Christopher McCabe, PhD
University of Birmingham, Birmingham, United Kingdom
 
Paid users only - purchase
Slides + audio
 
 
Available
from ENDO 2021 on March 20, 2021 11:00 AM-12:30 PM
What's New in 131-I Refractory Thyroid Cancer?
Developing Novel Combination Therapies for Medullary Thyroid Cancer
Rozita Bagheri-Yarmand, PhD
University of Texas MD Anderson Cancer Center, Houston, TX
 
Paid users only - purchase
Slides + audio
 
 
Available
from ENDO 2021 on March 20, 2021 11:00 AM-12:30 PM
What's New in 131-I Refractory Thyroid Cancer?
Genetic Determinants Underlying Radioiodine Refractory Thyroid Cancer
Sissy Jhiang, PhD
The Ohio State University Medical Center, Columbus, OH
 
Paid users only - purchase
Slides + audio
 
 
Available
from ENDO 2021 on March 20, 2021 11:00 AM-12:30 PM
What's New in 131-I Refractory Thyroid Cancer?
Abstract Presentation: Aggressive Thyroid Cancer is Associated With Suppressor Circulating Immunophenotype
Anupam Kotwal, MD
Univ. of Nebraska Medical Center, Omaha, NE
 
Paid users only - purchase
Slides + audio
 
 
Available
from ENDO 2021 on March 20, 2021 11:00 AM-12:30 PM
<< first | < prev page: of 1 records per page: next > | last >>
pages: 1 presentations: 1 to 4 of 4